Form 4: Masimo Director Wendy Lane Reports RSU Vesting and Grant

Director Wendy Lane acquired 1,225 shares of Masimo Corporation common stock through the vesting of restricted stock units and was granted 1,119 new restricted stock units.

Summary

• Director Wendy Lane exercised and vested 1,225 restricted stock units (RSUs) on April 29, 2026.
• The vested RSUs were converted into 1,225 shares of Masimo common stock at a price of $0 per share.
• Following the transaction, the director holds 2,608 shares of common stock directly.
• A new grant of 1,119 RSUs was awarded to the director on April 23, 2026, with a grant price of $178.71.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it reflects routine director compensation and equity management rather than a strategic shift or financial performance indicator.

Positives

• Director maintains a direct equity stake in the company, aligning interests with shareholders.

Negatives

• None identified; this is a standard compensatory equity transaction for a board member.

Risks

• None identified; this is a routine disclosure of director compensation.

Future Outlook

The newly granted RSUs are scheduled to vest in full on the earlier of the first anniversary of the grant date (April 23, 2027) or the date of the next annual meeting of stockholders.

Industry Context

StockSavvy.ai notes that this filing represents standard corporate governance and director compensation practices within the medical technology sector, where equity-based incentives are common for board retention.

Comparison to Industry Standards

• The use of RSU grants for board members is consistent with standard compensation practices for S&P 500 and mid-cap healthcare companies.
• The vesting schedule aligns with typical one-year cliff vesting cycles observed in the industry.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation disclosure.

Next Steps

• Vesting of the 1,119 RSUs granted on April 23, 2026, expected by April 2027.

Key Dates

Keywords

Masimo, MASI, Form 4, Insider Trading, Director Compensation, Restricted Stock Units